galactose has been researched along with ethylenediamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, C; Chen, CS; Cheng, SX; Jiang, XJ; Lu, B; Wang, T; Wu, DQ; Zhang, XZ; Zhang, YY; Zhuo, RX | 1 |
| Bondì, ML; Cavallaro, G; Craparo, EF; Giammona, G; Sardo, C; Serio, R; Zizzo, MG | 1 |
2 other study(ies) available for galactose and ethylenediamine
| Article | Year |
|---|---|
Galactosylated fluorescent labeled micelles as a liver targeting drug carrier.
Topics: Anti-Inflammatory Agents; Biocompatible Materials; Cell Line; Dextrans; Disaccharides; Drug Carriers; Drug Delivery Systems; Ethylenediamines; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Galactose; Humans; Liver; Materials Testing; Micelles; Molecular Structure; Particle Size; Polymers; Prednisone; Tissue Distribution | 2009 |
Galactosylated polymeric carriers for liver targeting of sorafenib.
Topics: Animals; Antineoplastic Agents; Biological Availability; Drug Carriers; Ethylenediamines; Female; Galactose; Kidney; Liver; Lung; Mice, Inbred C57BL; Micelles; Niacinamide; Peptides; Phenylurea Compounds; Polyesters; Sorafenib; Spleen | 2014 |